EODData

SHG, 605116: Aurisco Pharmaceutical Co Ltd

24 Sep 2026
LAST:

19.60

CHANGE:
 0.36
OPEN:
19.96
HIGH:
20.11
ASK:
0.00
VOLUME:
1.51M
CHG(%):
1.80
PREV:
19.96
LOW:
19.53
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Sep 2619.9620.1119.5319.601.51M
23 Sep 2620.0320.2319.9519.961.45M
22 Sep 2620.1020.3220.0120.081.97M
21 Sep 2619.7720.2819.7720.182.79M
18 Sep 2619.3019.9019.2819.762.85M
17 Sep 2618.9019.3218.9019.281.3M
16 Sep 2619.0019.1018.7619.101.02M
15 Sep 2619.2119.2618.9318.97839.9K
14 Sep 2618.9319.1418.7319.121.26M
11 Sep 2619.2119.3018.8118.901.67M

PROFILE

Name:Aurisco Pharmaceutical Co Ltd
About:Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides dexamethasone is used to treat skin diseases; fluticasone propionate preparations are used to treat asthma and allergic rhinitis; fluticasone furoate preparations are used to treat asthma, allergic rhinitis, and chronic obstructive pulmonary disease; eplerenone preparations are used for the treatment of hypertension and heart failure; bepedalic acid preparations are used for the treatment of hypercholesterolemia or atherosclerotic cardiovascular diseases; tenofovir used for the treatment of HIV-1 infection and chronic hepatitis B; pregabalin preparations are used to treat neuropathic pain, fibromyalgia, epilepsy, etc.; brivaracetam preparations are used to treat epilepsy; abiraterone acetate preparation for the treatment of prostate cancer; enzalutamide preparation for the treatment of prostate cancer; and dydrogesterone preparations are used to treat dysmenorrhea, endometriosis, irregular menstrual cycle, etc. In addition, the company provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Sector:Healthcare
Industry:Biotechnology
Address:Badu Industrial Park Zone, Tiantai, China, 317200
Website:https://www.aurisco.com
ISIN:CNE1000042S4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:20.78 
Forward P/E:15.71 
PEG Ratio:15.71 
Price to Sales:4.81 
Price to Book:2.96 
Profit Margin:0.23 
Operating Margin:0.24 
Return on Assets:0.07 
Return on Equity:0.15 
DivYield:0.01 
Div/Share:0.29 
Revenue:1.685B 
EBITDA:503.85M 
Shares:406.2M 
Market Cap:7.961B 

TECHNICAL INDICATORS

MA5:19.921.6%
MA10:19.500.5%
MA20:19.640.2%
MA50:19.851.3%
MA100:20.042.2%
MA200:23.0817.8%
STO9:46.67
STO14:49.30
RSI14:49.45
WPR14:-45.31
MTM14:0.02
ROC14:0.00 
ATR:0.43 
Week High:20.323.7%
Week Low:18.903.7%
Month High:20.625.2%
Month Low:18.7317.8%
Year High:35.5881.5%
Year Low:18.098.3%
Volatility:53.74 

RECENT DIVIDENDS

Date Amount
20 Jun 2025$0.29
06 Jun 2024$0.22
22 May 2023$0.16
06 Jun 2022$0.13